What Challenges Exist in Nanotechnology-Based Vaccine Development?
Despite its advantages, there are challenges in developing nanotechnology-based vaccines:
Regulatory Hurdles: Nanotechnology-based products face stringent regulatory requirements to ensure safety and efficacy. Manufacturing Complexity: The production of nanoparticles requires sophisticated technology and can be costly. Immunogenicity Concerns: There is a risk that nanoparticles themselves may trigger unwanted immune responses. Long-term Safety: The long-term effects of nanoparticles in the body are not fully understood and require extensive research.
